Researchers Use CRISPR To Boost Cancer Immunotherapy

HealthDay (11/10, Thompson) reported, “Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say.” The investigators “used…CRISPR to alter immune cells drawn from 16 patients who had a variety of solid cancers, including colon, breast and lung.” The findings were published in Nature and will be presented at the annual meeting of the Society for Immunotherapy of Cancer.